Literature DB >> 14512562

Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.

Mary Jane McWilliams1, John G Julias, Stefan G Sarafianos, W Gregory Alvord, Edward Arnold, Stephen H Hughes.   

Abstract

The RNase H activity of retroviral reverse transcriptases (RTs) degrades viral genomic RNA after it has been copied into DNA, removes the tRNA used to initiate negative-strand DNA synthesis, and generates and removes the polypurine tract (PPT) primer used to initiate positive-strand DNA synthesis. The cleavages that remove the tRNA and that generate and remove the PPT primer must be specific to generate linear viral DNAs with ends that are appropriate for integration into the host cell genome. The crystal structure of human immunodeficiency virus type 1 (HIV-1) RT in a complex with an RNA/DNA duplex derived from the PPT revealed that the 5' end of the PPT deviates from traditional Watson-Crick base pairing. This unusual structure may play a role in the proper recognition of the PPT by HIV-1 RT. We made substitution mutations in the 5' end of the PPT and determined their effects on virus titer. The results indicated that single and double mutations in the 5' end of the PPT had modest effects on virus replication in a single-cycle assay. More complex mutations had stronger effects on virus titer. Analysis of the two-long-terminal-repeat circle junctions derived from infecting cells with the mutant viruses indicated that the mutations affected RNase H activity, resulting in the retention of PPT sequences on viral DNA. The mutants tested preferentially retained specific segments of the PPT, suggesting an effect on cleavage specificity. These results suggest that structural features of the PPT are important for its recognition and cleavage in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512562      PMCID: PMC224987          DOI: 10.1128/jvi.77.20.11150-11157.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

2.  Plus-strand origin for human immunodeficiency virus type 1: implications for integration.

Authors:  K A Pullen; J J Champoux
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Deletion of a short, untranslated region adjacent to the polypurine tract in Moloney murine leukemia virus leads to formation of aberrant 5' plus-strand DNA ends in vivo.

Authors:  E Bacharach; J Gonsky; D Lim; S P Goff
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase.

Authors:  R Repaske; J W Hartley; M F Kavlick; R R O'Neill; J B Austin
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  A detailed model of reverse transcription and tests of crucial aspects.

Authors:  E Gilboa; S W Mitra; S Goff; D Baltimore
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

6.  Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.

Authors:  S G Sarafianos; K Das; C Tantillo; A D Clark; J Ding; J M Whitcomb; P L Boyer; S H Hughes; E Arnold
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

7.  Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H.

Authors:  A J Rattray; J J Champoux
Journal:  J Mol Biol       Date:  1989-08-05       Impact factor: 5.469

8.  Sequence of the circle junction of human immunodeficiency virus type 1: implications for reverse transcription and integration.

Authors:  J M Whitcomb; R Kumar; S H Hughes
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

9.  Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities.

Authors:  E S Furfine; J E Reardon
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

10.  Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids.

Authors:  B M Wöhrl; K Moelling
Journal:  Biochemistry       Date:  1990-11-06       Impact factor: 3.162

View more
  15 in total

1.  Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

3.  The fourth central polypurine tract guides the synthesis of prototype foamy virus plus-strand DNA.

Authors:  Dongxue Chen; Jing Song; Yan Sun; Zhi Li; Didi Wen; Qingmei Liu; Wanhong Liu; Xiaohua He
Journal:  Virus Genes       Date:  2017-02-09       Impact factor: 2.332

Review 4.  Recent findings on the mechanisms involved in tenofovir resistance.

Authors:  Pinar Iyidogan; Karen S Anderson
Journal:  Antivir Chem Chemother       Date:  2014-12-16

5.  Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Alternate polypurine tracts affect rous sarcoma virus integration in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity.

Authors:  Lesa R Miles; Beth E Agresta; Mahfuz B Khan; Shixing Tang; Judith G Levin; Michael D Powell
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.

Authors:  Kevin W Chang; John G Julias; W Gregory Alvord; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Mutations in the human immunodeficiency virus type 1 polypurine tract (PPT) reduce the rate of PPT cleavage and plus-strand DNA synthesis.

Authors:  M J McWilliams; J G Julias; S H Hughes
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.